Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 12/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6021060 | 0.82 | EPHX1 (0.42) | EPHX1ACHE | |
| SCHEMBL6021272 | 0.81 | CTSS (0.37) | CTSLCTSBCTSSCTSK | |
| SCHEMBL6021053 | 0.81 | CTSS (0.51) | EPHX1ACHECTSLCTSBCTSS | |
| SCHEMBL6020802 | 0.81 | EPHX1 (0.40) | EPHX1ACHE | |
| SCHEMBL6021573 | 0.77 | NPC1 (0.36) | EPHX1ACHECTSLCTSBCTSS | |
| SCHEMBL6019979 | 0.77 | CTSL (0.58) | CTSLCTSBCTSSCTSK | |
| SCHEMBL6019461 | 0.76 | CTSS (0.56) | CTSLCTSBCTSSCTSK | |
| SCHEMBL6020269 | 0.75 | SMN1; SMN2 (0.34) | EPHX1ACHECTSLCTSBCTSS | |
| SCHEMBL6019157 | 0.72 | CTSB (0.52) | CTSLCTSBCTSSCTSK | |
| SCHEMBL6021079 | 0.72 | CTSL (0.60) | CTSLCTSBCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060252813-A1 | Apparatus for curing a composite laminate | JERINI AG (DE) | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252813-A1 | Apparatus for curing a composite laminate | DHX29, HDHD5, DHRS9 | EPHX1 22/4885ACHE 849/4885CTSL 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.